PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction.

2 December 2022 (11:26 - 11:36)
Organised by:
Congress Presentation Part of: Hot Line: Intervention Interventional Cardiology ESC Professional Premium Access ESC Asia 2022 with APSC & AFC